Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Labat AfricaSTU:LAO Forward Dividend Yield % is 52.57% as of Aug. 08, 2026. The stock has 5 warning signs investors should review. Among 510 Drug Manufacturers companies, Labat Africa ranks better than 99.8% on this metric.
As of today (2026-08-08), the Forward Annual Dividend Yield of Labat Africa is 52.57%.
As of today (2026-08-08), the Trailing Annual Dividend Yield of Labat Africa is 52.57%.
STU:LAO's Forward Dividend Yield % is ranked better than 99.8% of 510
companies
in the Drug Manufacturers industry
Industry Median: 1.995
vs STU:LAO: 52.57
Labat Africa (STU:LAO) Forward Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Labat Africa Forward Dividend Yield % Related Terms
STU:LAO vs ZTS, UTHR, VTRS: Forward Dividend Yield % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Labat Africa's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Labat Africa Forward Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Labat Africa's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Labat Africa's Forward Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Labat Africa Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
ZAR 0.010000
2026-07-29
2026-07-31
0000-00-00
Cash Dividend
annually
ZAR:EUR 0.053140
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Labat Africa's Forward Annual Dividend Yield (%) for Today is calculated as
Labat Africa's Trailing Annual Dividend Yield (%) for Today is calculated as
Trailing Annual Dividend Yield
=
Most Recent Full Year Dividend
/
Current Share Price
=
0.0005314
/
0.001
=
53.14 %
Current Share Price is €0.001. Labat Africa's Dividends per Share for the trailing twelve months (TTM) ended in Today is €0.0005314.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Forward Dividend Yield % of 52.57% mean?
Labat Africa (STU:LAO) has a Forward Dividend Yield % of 52.57% as of Aug. 08, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Labat Africa and its competitors. According to the industry distribution chart, Labat Africa ranks #1 out of 510 companies in the Drug Manufacturers industry, placing it in the top 0.2%.
Is Labat Africa's Forward Dividend Yield % too high?
Labat Africa's current Forward Dividend Yield % is 52.57%. The Drug Manufacturers industry median Forward Dividend Yield % is 2.00. Labat Africa's value of 52.57% is 2535.1% above this industry median. Based on the distribution chart, Labat Africa ranks #1 out of 510 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does Labat Africa's Forward Dividend Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Labat Africa ranks #1 out of 510 companies for Forward Dividend Yield %. This places Labat Africa in the top 0% of its industry — outperforming the majority of peers. The industry median Forward Dividend Yield % is 2.00. Labat Africa's value of 52.57% is 2535.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Drug Manufacturers company?
The median Forward Dividend Yield % among Drug Manufacturers companies is 2.00, based on 510 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Labat Africa's current Forward Dividend Yield % of 52.57% is 2535.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Labat Africa and its competitors. For the Drug Manufacturers industry, the median Forward Dividend Yield % is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Labat Africa's current Forward Dividend Yield % is 52.57%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Labat Africa stock overvalued right now?
Based on GuruFocus' analysis, Labat Africa (STU:LAO) is currently considered Possible Value Trap. The stock's GF Value™ is €0.01, compared to a current price of €0.00 — trading 90% below its estimated fair value. The current Forward Dividend Yield % is 52.57% and 2535.1% above the Drug Manufacturers industry median of 2.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Labat Africa (STU:LAO), the current Forward Dividend Yield % is 52.57% as of Aug. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Labat Africa Ltd is an investment holding company. Through its subsidiaries, the company operates in the following segments; Technology, Head office, and Healthcare. The Technology segment manufactures and distributes integrated circuits South African Micro - Electronic Systems. Head office operations provide management services, logistics and seeks further investment opportunities for the Group. The Healthcare segment generates maximum revenue for the company and focusses on medical cannabis industry in South Africa. Geographically, the company carries out its business operations in South Africa.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:LAO has been successfully added to your 
